MedPath

Role of Magnesium Sulfate in children having Bronchiolitis

Phase 4
Conditions
Health Condition 1: null- Infants 1 month to 24 months of age presenting to pediatric emergency and OPD with diagnosis of bronchiolitis and Bronchiolitis severity score of 4.
Registration Number
CTRI/2018/06/014400
Lead Sponsor
All India Institute of Medical Sciences Jodhpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Infants 1 month to 24 months of age presenting to pediatric emergency /OPD with diagnosis of bronchiolitis and BSS of > 4.

2.Guardian of patients willing to give informed consent

Exclusion Criteria

1.Previous history of wheezing

2.Those requiring mechanical ventilation.

3.Children with hemodynamically significant heart disease, chromosomal anomalies, immunodeficiency, cystic fibrosis, bronchopulmonary dysplasia and epileptic encephalopathy)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To compare improvement of bronchiolitis severity scores in between two treatment groups.Timepoint: These will be taken at 0,1,2, 4,8,12,16 and 24 hours
Secondary Outcome Measures
NameTimeMethod
1.Need for admission to intensive care unit during the initial visit in both the groups. <br/ ><br>2.Within 2 weeks after discharge: <br/ ><br>i.Need for clinic revisit <br/ ><br>ii.Need for hospital admission <br/ ><br>iii.Need for ICU admission <br/ ><br>Timepoint: These will be taken at 0,1,2, 4,8,12, 16 and 24 hours
© Copyright 2025. All Rights Reserved by MedPath